Published 1 day ago • loading... • Updated 19 hours ago

Swiss Biotech Returns to Boehringer Ingelheim to Partner on Autoimmune T Cell Engager

CDR-Life has inked a second licensing pact with Boehringer Ingelheim, as the Zurich-based startup will work with the German drug company in a ripe area of dealmaking. For 38 million Swiss francs (about $48 million) ...

9 Articles

Globe Newswire

+6 Reposted by 6 other sources

Center

Boehringer Ingelheim and CDR-Life Expand Collaboration Efforts with Global Licensing Agreement for CDR111, an Antibody-Based Trispecific M-gager® for Autoimmune Diseases

Boehringer has licensed CDR111 from CDR-Life, an antibody-based trispecific M-gager® for autoimmune diseases. ...

22 hours ago

Read Full Article

Lyon Capitale

Rhône : 146 Jobs Threatened at Boehringer Ingelheim, a "Dismantlement" for Fo

The German company Boehringer Ingelheim would indeed plan to abolish 146 posts throughout the department. A very bad news for the Gerland site (headquarters of the company in France located in the 7th arrondissement), which would be "highly impacted", worries the union Force Ouvrière in a press release this [...] L-article Rhône: 146 jobs threatened at Boehringer Ingelheim, a "dismantlement" for FO appeared first on Lyon Capitale.

19 hours ago

Read Full Article